Literature DB >> 23248714

Conflicts of interest among authors of medical guidelines: an analysis of guidelines produced by German specialist societies.

Thomas Langer1, Susann Conrad, Liat Fishman, Martin Gerken, Sabine Schwarz, Beate Weikert, Günter Ollenschläger, Susanne Weinbrenner.   

Abstract

BACKGROUND: Conflicts of interest can bias the recommendations of clinical guidelines. In 2010, the Association of Scientific Medical Societies in Germany (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, AWMF) revised its rules about how conflicts of interest in guidelines should be managed.
METHODS: All S2 and S3 guidelines in the AWMF database that were created in the years 2009-2011 were independently examined by two reviewers each (TL, MG, SC, BW, LF, SS). Information on conflicts of interest was extracted and descriptively analyzed. The effects of the new AWMF rules were studied with a before-and-after comparison.
RESULTS: 60 (20%) of the 297 guidelines studied contained explicit declarations of conflict of interest by their authors. 680 authors (49%) stated that they had financial relationships that constituted a conflict of interest; 86% declared conflicts arising from membership in specialty societies or professional associations. From 2009 to 2011, there was a substantial rise in the frequency of conflict-of-interest declarations in guidelines (8% of 256 guidelines that were created before the AWMF revised its rules in 2010 and 95% of 41 guidelines created afterward). The percentage of persons declaring financial conflicts of interest rose after the new rules were introduced, while the mode of documentation of conflict-of-interest evaluation and of any measures that might have been taken as a result remained unchanged.
CONCLUSION: From 2011 onward, all conflict-of-interest declarations by guideline authors have been published in the AWMF database. There is no current standard for the evaluation and management of conflicts of interest in guideline-creating groups, and this situation urgently needs to be remedied.

Entities:  

Mesh:

Year:  2012        PMID: 23248714      PMCID: PMC3523262          DOI: 10.3238/arztebl.2012.0836

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  14 in total

1.  Relationships between authors of clinical practice guidelines and the pharmaceutical industry.

Authors:  Niteesh K Choudhry; Henry Thomas Stelfox; Allan S Detsky
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

2.  Financial ties between DSM-IV panel members and the pharmaceutical industry.

Authors:  Lisa Cosgrove; Sheldon Krimsky; Manisha Vijayaraghavan; Lisa Schneider
Journal:  Psychother Psychosom       Date:  2006       Impact factor: 17.659

3.  Differences in review quality and recommendations for publication between peer reviewers suggested by authors or by editors.

Authors:  Sara Schroter; Leanne Tite; Andrew Hutchings; Nick Black
Journal:  JAMA       Date:  2006-01-18       Impact factor: 56.272

4.  Cash interests taint drug advice.

Authors:  Rosie Taylor; Jim Giles
Journal:  Nature       Date:  2005-10-20       Impact factor: 49.962

5.  Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.

Authors:  David J Rothman; Walter J McDonald; Carol D Berkowitz; Susan C Chimonas; Catherine D DeAngelis; Ralph W Hale; Steven E Nissen; June E Osborn; James H Scully; Gerald E Thomson; David Wofsy
Journal:  JAMA       Date:  2009-04-01       Impact factor: 56.272

6.  Methodology for antithrombotic and thrombolytic therapy guideline development: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th Edition).

Authors:  Holger J Schünemann; Deborah Cook; Gordon Guyatt
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

7.  Understanding financial conflicts of interest.

Authors:  D F Thompson
Journal:  N Engl J Med       Date:  1993-08-19       Impact factor: 91.245

8.  [Self-help groups conflicts of interest through sponsoring by the pharmaceutical industry].

Authors:  D Klemperer
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2009-01       Impact factor: 1.513

9.  Knowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research.

Authors:  Jeffrey R Lacasse; Jonathan Leo
Journal:  BMC Res Notes       Date:  2011-01-31

10.  Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study.

Authors:  Jennifer Neuman; Deborah Korenstein; Joseph S Ross; Salomeh Keyhani
Journal:  BMJ       Date:  2011-10-11
View more
  12 in total

1.  Declaration and Handling of Conflicts of Interest in Guidelines: A Study of S1 Guidelines From German Specialist Societies From 2010-2013.

Authors:  Gisela Schott; Klaus Lieb; Jochem König; Bernd Mühlbauer; Wilhelm Niebling; Henry Pachl; Stephan Schmutz; Wolf-Dieter Ludwig
Journal:  Dtsch Arztebl Int       Date:  2015-06-26       Impact factor: 5.594

2.  Risk awareness and transparency.

Authors:  Rolf Kreienberg; Ina B Kopp
Journal:  Dtsch Arztebl Int       Date:  2013-04       Impact factor: 5.594

3.  In reply.

Authors:  Thomas Langer; Susann Conrad; Liat Fishman; Günter Ollenschläger; Sabine Schwarz
Journal:  Dtsch Arztebl Int       Date:  2013-04       Impact factor: 5.594

4.  Balancing conflicts of interest.

Authors:  Franz Porzsolt
Journal:  Dtsch Arztebl Int       Date:  2013-04       Impact factor: 5.594

5.  In reply.

Authors:  Gisela Schott; Henry Pachl; Wolf-Dieter Ludwig; Claudia Dünnweber; Bernd Mühlbauer; Wilhelm Niebling
Journal:  Dtsch Arztebl Int       Date:  2014-01-17       Impact factor: 5.594

6.  Transparency is key.

Authors:  Markus Follmann
Journal:  Dtsch Arztebl Int       Date:  2014-01-17       Impact factor: 5.594

7.  Does the pharmaceutical industry influence guidelines?: two examples from Germany.

Authors:  Gisela Schott; Claudia Dünnweber; Bernd Mühlbauer; Wilhelm Niebling; Henry Pachl; Wolf-Dieter Ludwig
Journal:  Dtsch Arztebl Int       Date:  2013-09-02       Impact factor: 5.594

Review 8.  Financial Conflicts of Interest in Clinical Practice Guidelines: A Systematic Review.

Authors:  Sahar Tabatabavakili; Rishad Khan; Michael A Scaffidi; Nikko Gimpaya; David Lightfoot; Samir C Grover
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-01-19

9.  Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.

Authors:  Camilla Hansen Nejstgaard; Lisa Bero; Asbjørn Hróbjartsson; Anders W Jørgensen; Karsten Juhl Jørgensen; Mary Le; Andreas Lundh
Journal:  Cochrane Database Syst Rev       Date:  2020-12-08

10.  Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.

Authors:  Adrienne Shnier; Joel Lexchin; Mirna Romero; Kevin Brown
Journal:  BMC Health Serv Res       Date:  2016-08-15       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.